The variables analyzed were as follows: age, sex, tumor distance from the anal margin, tumor size (cT) and number of positive lymph nodes (cN), histological grade and CEA at diagnosis, tumor distance to the mesorectal fascia (measured by MRI at diagnosis), and the interval of time from neoadjuvant therapy to surgery. The gene discussed is CEACAM5; the disease is neoplasm.